MetLife, Inc. (NYSE:MET) Shares Sold by XTX Topco Ltd

XTX Topco Ltd reduced its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 79.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,163 shares of the financial services provider's stock after selling 42,095 shares during the quarter. XTX Topco Ltd's holdings in MetLife were worth $914,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Retirement Wealth Solutions LLC bought a new stake in MetLife in the 4th quarter worth about $32,000. Sierra Ocean LLC bought a new position in MetLife in the 4th quarter worth $32,000. Graney & King LLC bought a new position in shares of MetLife during the 4th quarter valued at approximately $34,000. Values First Advisors Inc. bought a new position in shares of MetLife in the fourth quarter worth approximately $36,000. Finally, Golden State Wealth Management LLC purchased a new stake in MetLife in the 4th quarter worth $44,000. 94.99% of the stock is owned by hedge funds and other institutional investors.

MetLife Stock Up 1.1 %

Shares of MET stock traded up $0.79 during mid-day trading on Friday, hitting $72.49. The stock had a trading volume of 2,739,216 shares, compared to its average volume of 3,407,370. The firm has a market capitalization of $49.38 billion, a P/E ratio of 12.14, a price-to-earnings-growth ratio of 0.65 and a beta of 0.89. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The firm's 50-day moving average is $79.19 and its two-hundred day moving average is $82.13.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on MET shares. Barclays reduced their price objective on shares of MetLife from $95.00 to $88.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Piper Sandler increased their price target on MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. UBS Group lifted their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods reduced their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, Wells Fargo & Company dropped their target price on MetLife from $97.00 to $91.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $92.46.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.